Goldman Sachs’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Buy
754,151
+256,984
+52% +$9.13M ﹤0.01% 2253
2025
Q4
$17.9M Buy
497,167
+284,305
+134% +$10.4M ﹤0.01% 2494
2025
Q3
$6.7M Sell
212,862
-28,940
-12% -$1.04M ﹤0.01% 3375
2025
Q2
$10.3M Sell
241,802
-129,684
-35% -$5.4M ﹤0.01% 2732
2025
Q1
$16.6M Buy
371,486
+44,333
+14% +$2.39M ﹤0.01% 2206
2024
Q4
$18M Buy
327,153
+125,949
+63% +$6.38M ﹤0.01% 2224
2024
Q3
$8.5M Buy
201,204
+47,742
+31% +$2.27M ﹤0.01% 2878
2024
Q2
$7.04M Sell
153,462
-40,895
-21% -$1.93M ﹤0.01% 2846
2024
Q1
$10.1M Sell
194,357
-277,838
-59% -$12.2M ﹤0.01% 2455
2023
Q4
$16.8M Sell
472,195
-10,779
-2% -$375K ﹤0.01% 2067
2023
Q3
$16.2M Buy
482,974
+217,731
+82% +$7.55M ﹤0.01% 1983
2023
Q2
$9.97M Sell
265,243
-11,610
-4% -$382K ﹤0.01% 2456
2023
Q1
$8.12M Buy
276,853
+87,099
+46% +$2.52M ﹤0.01% 2623
2022
Q4
$5M Sell
189,754
-26,516
-12% -$631K ﹤0.01% 3164
2022
Q3
$5.02M Sell
216,270
-5,598
-3% -$153K ﹤0.01% 3133
2022
Q2
$5.59M Buy
221,868
+17,593
+9% +$519K ﹤0.01% 3034
2022
Q1
$7.81M Buy
204,275
+11,308
+6% +$408K ﹤0.01% 2939
2021
Q4
$7.58M Sell
192,967
-65,418
-25% -$2.87M ﹤0.01% 3012
2021
Q3
$12.6M Buy
258,385
+42,744
+20% +$2.21M ﹤0.01% 2490
2021
Q2
$11.3M Sell
215,641
-175,846
-45% -$10M ﹤0.01% 2573
2021
Q1
$21.7M Sell
391,487
-424,679
-52% -$19.2M 0.01% 1866
2020
Q4
$25.2M Buy
816,166
+13,681
+2% +$326K 0.01% 1661
2020
Q3
$14.9M Buy
802,485
+493,897
+160% +$8.17M ﹤0.01% 1982
2020
Q2
$4.26M Buy
308,588
+59,407
+24% +$804K ﹤0.01% 2918
2020
Q1
$2.29M Sell
249,181
-183,957
-42% -$2.76M ﹤0.01% 3205
2019
Q4
$7.54M Buy
433,138
+170,713
+65% +$2.91M ﹤0.01% 2650
2019
Q3
$3.97M Sell
262,425
-59,949
-19% -$1.05M ﹤0.01% 3040
2019
Q2
$6.09M Sell
322,374
-32,327
-9% -$551K ﹤0.01% 2717
2019
Q1
$6.21M Sell
354,701
-198,755
-36% -$3.63M ﹤0.01% 2796
2018
Q4
$9.63M Buy
553,456
+22,705
+4% +$340K ﹤0.01% 2372
2018
Q3
$7.51M Sell
530,751
-428,870
-45% -$5.03M ﹤0.01% 2669
2018
Q2
$9.31M Buy
959,621
+560,670
+141% +$6.98M ﹤0.01% 2460
2018
Q1
$3.97M Buy
398,951
+379,751
+1,978% +$3.14M ﹤0.01% 3076
2017
Q4
$105K Buy
+19,200
New +$88.6K ﹤0.01% 5721
2017
Q2
Sell
-20,037
Closed -$56K 6990
2017
Q1
$56K Sell
20,037
-22,311
-53% -$63.1K ﹤0.01% 6259
2016
Q4
$127K Buy
+42,348
New +$109K ﹤0.01% 6025
2016
Q2
Sell
-47,471
Closed -$278K 7266
2016
Q1
$278K Buy
47,471
+30,568
+181% +$85.7K ﹤0.01% 5333
2015
Q4
$44K Buy
+16,903
New +$37.8K ﹤0.01% 6606

Other funds holding VCEL

Goldman Sachs's VCEL Position: Q1 2026 in Review

Goldman Sachs increased its Vericel Corp (VCEL) stake by 52% in Q1 2026, buying an estimated $9.13M and bringing the position to 754,151 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Goldman Sachs first reported a position in VCEL in Q4 2015 and has held it in 38 quarters since. The position peaked at $25.2M in Q4 2020. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Goldman Sachs held 754,151 shares of Vericel Corp worth $24.3M as of Q1 2026.
  • Goldman Sachs bought 256,984 Vericel Corp shares in Q1 2026, an estimated $9.13M.
  • Vericel Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2253 holding.
  • Goldman Sachs first reported a position in Vericel Corp in Q4 2015 and has held it in 38 quarters since.
  • Goldman Sachs's Vericel Corp position peaked at $25.2M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.